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Background:  Low high-density lipoprotein cholesterol (HDL-C) is a potent risk factor for atherosclerosis. Yet, the long-term prognostic significance 
of HDL-C levels after an acute myocardial infarction and among older adults is not known.
Methods:  We evaluated 24,805 patients with non-ST-segment elevation myocardial infarction (NSTEMI) aged >65 years and enrolled at 434 
hospitals participating in CRUSADE (Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation 
of the ACC/AHA Guidelines) from 2003 to 2006. Clinical data were linked to Medicare files to assess longitudinal patient outcomes (median 
follow-up 2.9 years). The association of categorical HDL-C level measured at initial hospitalization and all-cause mortality was investigated using a 
multivariable Cox proportional hazard regression model.
Results:  The median age of the patients was 77 years; the majority was white (86%) and male (54%). The overall mortality rate was 39.5%. Overall, 
49.7% of NSTEMI patients had low or very low HDL-C. Compared with patients with normal HDL-C, those with very low HDL-C had significantly higher 
long-term mortality after adjusting for major risk factors (Table).
Conclusions:  Even among older patients, low HDL-C is a continued predictor of increased long-term mortality following NSTEMI. These patients 
may benefit from more aggressive cardiovascular risk reduction efforts. 
Table. Hazard ratios (HR) for long-term mortality by HDL-C category (Reference for HR: normal HDL-C [41-60 mg/dL])
HDL category Number of patients, n (%)
Mortality,
n (%)
Adjusted HR (95% CI)
(c-index 0.75)
P-value
Very low
(<30 mg/dL)
4475 (18.04) 1898 (42.41) 1.12 (1.05-1.18) 0.0002
Low
(31-40 mg/dL)
7854 (31.66) 3017 (38.41) 1.04 (0.99-1.09) 0.1063
Normal
(41-60 mg/dL)
9905 (39.93) 3825 (38.62) -- -- -- --
High
(>60 mg/dL)
2571 (10.36) 1068 (41.54) 1.04 (0.97-1.12) 0.2266
